Urachal adenocarcinoma is an unusual non-urothelial bladder malignancy that often presents at advanced stages with poor prognosis. It is a rare malignancy accounting for an estimated 0.01% of all adult cancers and 0.5%-2.0% of all bladder malignancies. It is important to recognize the diagnosis earlier due to the differences in treatment options in comparison to urothelial carcinoma. We present a case of urachal adenocarcinoma with cervical involvement. A 42 year-old African American woman presented for evaluation due to a one-month history of abdominal pain and spotting. On physical examination, a large, firm, immobile cervical mass was present with necrotic debris filling the vagina. Grossly, the mass seemed to arise from the cervix. A biopsy of the mass was performed demonstrating moderately differentiated mucinous adenocarcinoma, an uncommon type of primary cervical carcinoma. Immunohistochemistry (IHC) studies showed malignant cells positive for CK20, CK7, CDX-2, and CEA; membrane and cytoplasmic staining for beta-catenin; and no nuclear translocation of beta-catenin protein. It was a challenge to differentiate between urachal adenocarcinoma and colorectal carcinoma because both stain positive for beta-catenin. A subsequent CT scan showed right-sided hydronephrosis, a 7.6 x 5.7 cm mass extending from the cervix to the uterus, and a 4.4 x 3.5 cm exophytic mass extending from the bladder dome. Since the IHC showed CK7 and cytoplasmic beta-catenin positivity as well as a CT with mass at the bladder dome, a diagnosis of primary urachal adenocarcinoma was confirmed. Diagnosing urachal carcinoma from a cervical mass metastasis is very unusual. Establishing a primary diagnosis proves difficult, since no specific markers have been established to differentiate urachal adenocarcinoma from colorectal adenocarcinoma. More specific IHC markers for future detection and cytologic diagnosis are needed to further characterize metastatic urachal adenocarcinoma. Introduction: Angiofibroma of soft tissue is a recent recognized benign fibrovascular soft tissue tumor that arises in superficial or deep soft tissue, mainly of lower extremity and in relation to joints. A recurrent balanced t (5;8) chromosomal translocation has been reported associated with this entity and leads to an AHRR-NCOA2 gene fusion. Here we report a case of 67-year-old woman without significant past medical history who presented with a mass in the right thigh without any associated pain since three years ago. Methods: The surgical specimen was formalin fixed, thoroughly sampled, embedded in paraffin, cut in 6 um-thick sections and stained with hematoxylin and eosin. Immunohistochemical studies and molecular cytogenetic analysis were performed together with proper negative and positive control. Results: Grossly, serial sectioning revealed a 7.9 x 4.1 x 3.5 cm, well-demarcated, yellow-tan and red-brown, heterogeneous, intramuscular mass. Microscopically, this intramuscular lesion was sharply circumscribed from surrounding soft tissue, and histologically composed of short spindle, ovoid, and triangular cells interspersed in a focally myxoid background with a prominent vascular network, which was composed of small branching thin wall blood vessels. Mitotic figures were few. The lesional cells were focally positive for desmin, while negative for smooth muscle actin (SMA), S100, CD34, and CAM5.2. Molecular cytogenetic studies were positive for rearrangement of the NCOA2 (8q13.3) gene locus, thus supported the diagnosis of angiofibroma of soft tissue. While this lesion was negative for rearrangement of the DDIT3 and USP6 loci, which excluded the possibility of myxoid liposarcoma and nodular fasciitis, respectively. Conclusion: Here we presented a case of angiofibroma of soft tissue, and the diagnosis could be challenging by morphological similarity with other lesions such as myxoid liposarcoma and nodular fasciitis. However, molecular cytogenetic analysis can be very helpful by demonstrating a rearrangement of NCOA2 (8q13.3) gene locus. 
